Daniel Bejarano-Quisoboni
Overview
Explore the profile of Daniel Bejarano-Quisoboni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rajaonera D, Bejarano-Quisoboni D, Grill J, Allodji R, Pelletier-Fleury N, Journy N, et al.
BMC Neurol
. 2024 Sep;
24(1):335.
PMID: 39256648
Purpose: Childhood cancer survivors (CCS) have an increased risk of developing late chronic diseases, which can be influenced by the cancer type and its treatment. These chronic diseases can be...
2.
Dumas A, Milcent K, Bougas N, Bejarano-Quisoboni D, El Fayech C, Charreire H, et al.
Cancer
. 2023 Jul;
129(21):3476-3489.
PMID: 37432135
Background: Long-term follow-up (LTFU) clinics have been developed but only some childhood cancer survivors (CCS) attend long-term follow-up (LTFU). Objective: To identify factors that influence LTFU attendance. Methods: Five-year CCS...
3.
Bejarano-Quisoboni D, Panjo H, Fresneau B, El-Fayech C, Doz F, Surun A, et al.
Eur J Health Econ
. 2023 Jun;
25(3):513-523.
PMID: 37344685
Background: Due to late effects, childhood cancer survivors (CCS) are more likely to have multiple chronic conditions than the general population. However, little is known about the economic burden of...
4.
Mansouri I, Schwartz B, Vu-Bezin G, Bejarano-Quisoboni D, Fresneau B, El-Fayech C, et al.
Cancer Epidemiol Biomarkers Prev
. 2023 Jan;
32(4):572-581.
PMID: 36692978
Background: Hospitalization rates can be used as an indirect indicator of the burden and severity of adverse health outcomes in childhood cancer survivors (CCS). We aimed to determine the long-term...
5.
Gonzalez de Leon B, Abt-Sacks A, Acosta Artiles F, Del Pino-Sedeno T, Ramos-Garcia V, Rodriguez Alvarez C, et al.
Int J Environ Res Public Health
. 2022 Dec;
19(24).
PMID: 36554679
This study examines the experiences and expectations of patients with depressive disorders regarding the disease and different antidepressants, as well as examining the barriers and facilitating factors that could affect...
6.
Bejarano-Quisoboni D, Pelletier-Fleury N, Allodji R, Fresneau B, Boussac M, Pacquement H, et al.
Sci Rep
. 2022 Oct;
12(1):18068.
PMID: 36302943
The late effects of treatments for childhood cancers may lead to severe and multiple health conditions requiring hospitalisation. We aimed to estimate the hospitalisation rate among childhood cancer survivors (CCS)...
7.
Gonzalez de Leon B, Del Pino-Sedeno T, Serrano-Perez P, Rodriguez Alvarez C, Bejarano-Quisoboni D, Trujillo-Martin M
BMC Psychiatry
. 2022 Jul;
22(1):487.
PMID: 35858887
Background: Non-adherence to medication is a major obstacle in the treatment of depressive disorders. We systematically reviewed the literature to evaluate the effectiveness of interventions aimed at improving adherence to...
8.
Rodriguez-Bernal C, Sanchez-Saez F, Bejarano-Quisoboni D, Hurtado I, Garcia-Sempere A, Peiro S, et al.
Front Cardiovasc Med
. 2022 Jun;
9:863876.
PMID: 35694663
Aim: Adherence to multiple medications recommended for secondary prevention of cardiovascular conditions represents a challenge. We aimed to identify patterns of concurrent adherence to combined therapy and assess their impact...
9.
Bejarano-Quisoboni D, Pelletier-Fleury N, Allodji R, Lacour B, Grosclaude P, Pacquement H, et al.
PLoS One
. 2022 May;
17(5):e0267317.
PMID: 35617253
Background: Childhood cancer survivors (CCS) may require lifelong medical care due to late effects of cancer treatments. Little is known about of their healthcare utilization and expenditures at long-term especially...
10.
Rodriguez-Bernal C, Sanchez-Saez F, Bejarano-Quisoboni D, Riera-Arnau J, Sanfelix-Gimeno G, Hurtado I
Front Pharmacol
. 2021 Dec;
12:789783.
PMID: 34966283
Despite the continuous update of clinical guidelines, little is known about the real-world management of patients with atrial fibrillation (AF) who survived a stroke. We aimed to assess patterns of...